{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/vitiligo/background-information/risk-factors/","result":{"pageContext":{"chapter":{"id":"def00a0c-fcf5-5066-b8b6-d4197121b345","slug":"risk-factors","fullItemName":"Risk factors","depth":2,"htmlHeader":"<!-- begin field a1e40692-c310-4bba-a4b0-0b4a484cbffb --><h2>What are the risk factors?</h2><!-- end field a1e40692-c310-4bba-a4b0-0b4a484cbffb -->","summary":"","htmlStringContent":"<!-- begin item b92cecf5-e159-4505-b24d-9167fd3ffd1f --><!-- begin field 4b74c8f9-f894-4a2d-ad10-8d598b15728d --><p><strong>Possible risk factors for <a class=\"topic-reference internal-reference\" href=\"/topics/vitiligo/background-information/definition/\">non-segmental vitiligo</a> include:</strong></p><ul><li><strong>A family history of vitiligo.</strong><ul><li>There is a positive family history in 25–30% of people with vitiligo [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Plensdorf, 2017</a>].</li><li>About 20% of people with vitiligo have at least one first-degree relative with vitiligo, and the relative risk of vitiligo for first-degree relatives is increased by 7- to 10-fold [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Bergqvist, 2020</a>].</li><li>A retrospective notes review and interview-based study (n = 137 children with vitiligo) found that family history appears to be associated with earlier age of onset of vitiligo. There was no association between family history and site of onset, distribution, or course of disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Pajvani, 2006</a>].</li></ul></li><li><strong>A personal or family history of other autoimmune diseases,</strong> including [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Gawkrodger, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Ezzedine, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Bergqvist, 2020</a>]:<ul><li>Thyroid disease (most common, particularly Hashimoto's thyroiditis). See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hypothyroidism/\">Hypothyroidism</a> for more information.</li><li>Addison's disease, pernicious anaemia, systemic lupus erythematosus and discoid lupus, diabetes mellitus, alopecia areata, rheumatoid arthritis, psoriasis, inflammatory bowel disease, and Sjogren's syndrome. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/addisons-disease/\">Addison's disease</a>, <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-b12-folate-deficiency/\">Anaemia - B12 and folate deficiency</a>, <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a>, <a class=\"topic-reference external-reference\" href=\"/topics/alopecia-areata/\">Alopecia areata</a>, <a class=\"topic-reference external-reference\" href=\"/topics/rheumatoid-arthritis/\">Rheumatoid arthritis</a>, <a class=\"topic-reference external-reference\" href=\"/topics/psoriasis/\">Psoriasis</a>, <a class=\"topic-reference external-reference\" href=\"/topics/crohns-disease/\">Crohn's disease</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/ulcerative-colitis/\">Ulcerative colitis</a> for more information. </li></ul></li></ul><!-- end field 4b74c8f9-f894-4a2d-ad10-8d598b15728d --><!-- end item b92cecf5-e159-4505-b24d-9167fd3ffd1f -->","topic":{"id":"72501cc1-fbf6-5c3a-bfc1-1a2d865f7dff","topicId":"85a32b0f-cf7a-41c9-9dd8-caed21004663","topicName":"Vitiligo","slug":"vitiligo","lastRevised":"Last revised in April 2020","chapters":[{"id":"237f05d1-6751-5abf-98b0-af49db55e1b3","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"e51e2938-3e89-53a6-9251-b0376a90be4d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"5c590af0-29e5-5be3-958d-02f67350d529","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"aee2331c-c78c-5c0d-ba9a-c974cfb039ae","slug":"changes","fullItemName":"Changes"},{"id":"8afc6e46-c250-5eb3-85a1-355d3e18ee65","slug":"update","fullItemName":"Update"}]},{"id":"78bbc5cd-9e73-55fb-b421-d718417be14a","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"1a4f8e76-7634-54ba-8849-3051a448dccc","slug":"goals","fullItemName":"Goals"},{"id":"65dbcf54-b53e-54e8-a2fe-a07b8aae49f2","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ba868062-b333-5694-90cb-1b24ed0d9c11","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1912341a-6cf7-5d2a-b20d-cb4f55308c36","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"05992da2-cc78-5880-8307-5a5f8e4cc4da","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"30dc5858-bfd0-5918-b331-9067d9743f12","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"33d1fc44-e925-5b20-982d-7e60d75465ea","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"c23ed46f-6f85-51ef-9f34-aea63f9aea9e","slug":"definition","fullItemName":"Definition"},{"id":"cfca1785-6f25-546b-8fba-a9bb5ec8bc4f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"1c68db6d-01f9-5407-b229-ad9ba72d53b1","slug":"causes","fullItemName":"Causes"},{"id":"def00a0c-fcf5-5066-b8b6-d4197121b345","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"4b6c885f-0d2d-5b2c-abeb-495372e63081","slug":"complications","fullItemName":"Complications"},{"id":"63ac95a4-7b80-5aef-bf7b-cc1b8b812a1c","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"9b1dd44e-152a-5b47-8bbd-a07a6000032f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"465324e6-d6e2-5263-8c5d-9368e36b2d89","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"ebc547bc-2b3a-55f8-a703-fff4f5d4f309","slug":"assessment","fullItemName":"Assessment"},{"id":"dea3c9af-e347-5a61-8a6e-852afbca1f6b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"674a723c-f8af-5b44-b6fc-6d46ad281431","fullItemName":"Management","slug":"management","subChapters":[{"id":"d85da703-7350-5165-a4eb-3697e45db487","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"8ddf3c8a-0168-521b-a940-e841ebe05935","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"0f441642-e226-5709-89d2-b4f6eeee7a85","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"d538aa6d-327c-503c-b574-69a24bbfd9f0","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c5bed09a-eccb-5abe-8ff1-63f178d8c28c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f56b39ed-360e-5ae6-9103-c21bb5e9862d","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ba61933a-4f62-5bb3-988b-9749f78e6265","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"31c2bb80-d9f1-5095-b859-2ad42da47934","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a43f071b-fb92-55e3-a42d-348c5fd48924","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"33d1fc44-e925-5b20-982d-7e60d75465ea","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}